Actress Marissa Jaret Winokur Urges Women to “Take the Pledge” to Prevent Cervical Cancer

Posted on June 24th, 2008 by JKemp@zetainteractive.com

Actress Marissa Jaret Winokur Urges Women to “Take the Pledge” to Prevent Cervical Cancer

Each Pledge to Benefit Cervical Cancer Charities

Marissa Jaret Winokur, best known as a recent Dancing with the Stars semi-finalist and for her Tony-award winning role in the Broadway musical Hairspray, is calling on all women to “take the pledge to stop cervical cancer” by visiting www.theHPVtest.com/pledge. For each woman who pledges to spread the word to her family and friends and/or get the HPV test, QIAGEN – the company that developed the test for the primary cause of cervical cancer, the human papillomavirus – will donate $1 to two charities dedicated to educating women on the disease.

To help raise awareness of cervical cancer prevention and the online charity drive, Winokur –herself a cervical cancer survivor — recently spoke in New York City about her battle with the disease and the upcoming birth of her child. With the help of a surrogate, Winokur and her husband are expecting a baby boy, who they will name “Zev.” He is expected to arrive on or about July 22. View video and pictures from the event.

Webcast and Q&A with Marissa Jaret Winokur

Marissa’s Story

  • Learn more about Marissa’s battle with cervical cancer
  • Join Marissa in taking the pledge at www.theHPVtest.com/pledge, If you’re 30 or over, pledge to get the HPV test the next time you get your Pap. And, no matter what age you are, join with Marissa in spreading the word to other women!
  • Get an inside look at Marissa’s recent baby shower. View video or pictures.
  • Watch a Q&A Webcast for bloggers with Marissa and Dr. Marie Savard, an internist and author on patient empowerment.

The Facts about HPV:

  • HPV is a common virus that infects the skin and mucous membranes.
  • There are about 100 types of HPV. Approximately 30 of those are spread through genital contact (typically sexual intercourse). Around 13 "high-risk" types of HPV can cause cervical cancer.
  • It’s estimated that 80 percent of women will get an HPV infection by the age of 50. Although most of those infections will clear up on their own, those that persist can cause abnormal cells to develop into cervical cancer if not treated early.
  • Despite the many people it has helped, the Pap fails to identify some women with cervical disease – like it did for Marissa.
  • The digene HPV Test uses advanced molecular technology to detect the genetic “footprint” of the virus that causes abnormal cervical cells – HPV. It has been approved for use with a Pap for all women age 30 and over – who are most at risk of developing cervical cancer.
  • The new HPV vaccine does not provide complete protection, particularly for women who already have been exposed to the virus.
  • Test your HPV knowledge with a myths/facts quiz!

Participating Charities

  • Tamika & Friends is a national non-profit organization created to raise awareness about cervical cancer, its link to HPV and how to prevent it through a network of survivors, their friends and others who care about them. T&F was founded by Tamika Felder, a television producer and cervical cancer survivor who lives in Washington, DC.
  • TheYellow Umbrella.Org is a national non-profit organization founded to help spread the word through the unique enthusiasm and skills of Christine Baze, a cervical cancer survivor and singer/songwriter based in Boston.
MULTIMEDIA ELEMENTS
QUOTES

“I’m a lot more educated today, and I know that the Pap sometimes doesn’t catch abnormal cells early enough. That was the case for me. I didn’t know then that cervical cancer is caused by HPV, and that the Pap wasn’t enough to make sure that if I was at risk, I’d find out early. Today, I tell other women to get the HPV test with their Pap if they’re 30 or over.” – Marissa Jaret Winokur

“I am now having a baby boy with the help of a surrogate, which is a miracle. But there is a part of me that is sad that I can’t experience being pregnant or giving birth. I don’t want any other woman to have to go through what I did – or lose out on her chance to have a baby. Women should talk to their doctor about getting the HPV test along with their Pap, if they’re over 30.” – Marissa Jaret Winokur

“Combining the HPV test with a Pap for women over 30 is the best way to identify who is most likely to have or develop cervical cancer. The Pap has been very effective, but it only looks for abnormal cells caused by HPV. It can’t detect the presence of the virus itself.” – Dr. Marie Savard

“When testing shows a woman has a persistent infection with a high-risk type of HPV, her doctor or nurse is alerted to a possible problem, and can order the procedures necessary to find any abnormal cells and remove them – before they become cancer.” – Dr. Marie Savard

“The HPV vaccine that is getting so much attention today indeed helps protect against the two types of HPV that most commonly cause cervical cancer. But there are many other high-risk types of HPV that aren’t covered by the vaccine, so it doesn’t offer complete protection. All women still need to continue to get their Pap and – if they’re over 30 — HPV test for the rest of their lives.” – Dr. Marie Savard

“Cervical cancer is an almost entirely preventable disease. We have the necessary tools – the HPV test and vaccine, plus the Pap. Now we just need a lot more education, of both women and healthcare professionals. Tamika & Friends and The Yellow Umbrella Organization are particularly effective in reaching out to other women because they were founded by cervical cancer survivors, like Marissa. ” – Pam Rasmussen

About QIAGEN:

QIAGEN NV, headquartered in the Netherlands, is the leading global provider of sample and assay technologies. Sample technologies identify and separate DNA, RNA and proteins from blood, tissue, etc., and assays make these molecules visible for such vital activities as medical research, detection of disease and monitoring of treatment outcome. QIAGEN has developed and markets more than 500 products as well as instruments that make their use more efficient and accurate. The company provides its products to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. QIAGEN’s assay technologies include one of the broadest panels of molecular diagnostic tests available worldwide, including the only FDA-approved test for human papillomavirus (HPV), the primary cause of cervical cancer. QIAGEN employs more than 2,600 people in over 30 locations worldwide.

RELATED LINKS
CONTACT INFORMATION

Technorati Tags: | | | | | | | | | | | | | | | | | | | | | | | | | | |

Post a comment